Bharat Rasayan Limited (NSE:BHARATRAS)

Ligand Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	556.87	324.35	185.84	3.35	266.28
Short-Term Investments	-	2,301	922.02	300.12	-	1,059
Cash & Short-Term Investments	2,858	2,858	1,246	485.96	3.35	1,325
Cash Growth	102.94%	129.30%	156.48%	14410.54%	-99.75%	190.93%
Accounts Receivable	-	4,192	3,937	3,250	4,637	2,956
Other Receivables	-	-	948.17	593.47	262.74	297.89
Receivables	-	4,192	4,885	3,844	4,900	3,254
Inventory	-	2,904	2,666	3,231	2,772	1,686
Prepaid Expenses	-	-	13.49	16.2	13.35	10.98
Other Current Assets	-	974.49	258.03	331.16	278.45	228.16
Total Current Assets	-	10,928	9,069	7,908	7,967	6,504
Property, Plant & Equipment	-	2,447	2,362	2,351	2,390	2,085
Long-Term Investments	-	683.78	508.51	370.19	433.47	444.96
Other Intangible Assets	-	0.81	0.85	1.02	1.5	1.32
Other Long-Term Assets	-	21.74	33.53	105.8	63.99	43.98
Total Assets	-	14,081	11,974	10,736	10,856	9,079
Accounts Payable	-	1,421	728.3	748.11	681.59	611.94
Accrued Expenses	-	4.4	31.63	27.73	28.77	63.76
Short-Term Debt	-	852.19	804.74	279.37	1,726	584.46
Current Income Taxes Payable	-	9.89	-	22.07	28.96	60.63
Current Unearned Revenue	-	-	10.17	92.75	121.27	5.48
Other Current Liabilities	-	321.08	395.64	535.1	457.28	377.14
Total Current Liabilities	-	2,609	1,970	1,705	3,044	1,703
Long-Term Debt	-	-	-	-	10	-
Long-Term Deferred Tax Liabilities	-	152.66	109.18	84.13	88.46	90.2
Other Long-Term Liabilities	-	20.03	15.97	13.86	12.92	12.49
Total Liabilities	-	2,781	2,096	1,803	3,155	1,806
Common Stock	-	41.55	41.55	41.55	41.55	42.49
Retained Earnings	-	-	9,836	8,891	7,658	7,230
Comprehensive Income & Other	-	11,258	0.94	0.94	0.94	-
Shareholders' Equity	11,300	11,300	9,879	8,933	7,700	7,273
Total Liabilities & Equity	-	14,081	11,974	10,736	10,856	9,079
Total Debt	852.19	852.19	804.74	279.37	1,736	584.46
Net Cash (Debt)	2,006	2,006	441.63	206.59	-1,733	740.97
Net Cash Growth	232.34%	354.15%	113.77%	-	-	-
Net Cash Per Share	482.69	482.69	106.29	49.72	-417.04	174.39
Filing Date Shares Outstanding	4.16	4.16	4.16	4.16	4.16	4.25
Total Common Shares Outstanding	4.16	4.16	4.16	4.16	4.16	4.25
Working Capital	-	8,320	7,099	6,203	4,923	4,801
Book Value Per Share	2719.44	2719.44	2377.43	2149.82	1853.11	1711.77
Tangible Book Value	11,299	11,299	9,878	8,932	7,699	7,272
Tangible Book Value Per Share	2719.24	2719.24	2377.22	2149.57	1852.75	1711.46
Land	-	-	271.86	273.26	273.26	83.92
Buildings	-	-	1,083	1,059	1,054	979.56
Machinery	-	-	3,432	3,142	2,927	2,576
Construction In Progress	-	-	61.12	106.25	112.29	177.23

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.